{
"NDC": {
"NDCCode": "71124-0039-1",
"PackageDescription": "16 mL in 1 VIAL, GLASS (71124-0039-1) ",
"NDC11Code": "71124-0039-01",
"ProductNDC": "71124-0039",
"ProductTypeName": "DRUG FOR FURTHER PROCESSING",
"ProprietaryName": null,
"ProprietaryNameSuffix": null,
"NonProprietaryName": "Bevacizumab",
"DosageFormName": "INJECTION",
"RouteName": null,
"StartMarketingDate": "20240924",
"EndMarketingDate": null,
"MarketingCategoryName": "DRUG FOR FURTHER PROCESSING",
"ApplicationNumber": null,
"LabelerName": "Samsung BioLogics Co. LTD",
"SubstanceName": "BEVACIZUMAB-ADCD",
"StrengthNumber": "25",
"StrengthUnit": "mg/mL",
"Pharm_Classes": null,
"DEASchedule": null,
"Status": "Unfinished",
"LastUpdate": "2025-10-28",
"PackageNdcExcludeFlag": null,
"ProductNdcExcludeFlag": null,
"ListingRecordCertifiedThrough": "20261231",
"StartMarketingDatePackage": "24-SEP-24",
"EndMarketingDatePackage": null,
"SamplePackage": null
}
}